Search company, investor...


Founded Year



Unattributed | Alive

About Isogenica

Isogenica specializes in the discovery and optimization of therapeutic and diagnostic peptides, proteins and antibodies. The company has an exclusive license to in vitro display technology that allows the generation of polypeptide and antibody libraries from which it is possible to select lead molecules with high affinity and specificity for most targets.

Headquarters Location

Essex, England, CB10 1XL,

United Kingdom

+44 1799 533680

Missing: Isogenica's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Isogenica's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Isogenica Patents

Isogenica has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Biotechnology, Molecular biology, Clusters of differentiation, Peptides, Proteins


Application Date


Grant Date



Related Topics

Biotechnology, Molecular biology, Clusters of differentiation, Peptides, Proteins



Latest Isogenica News

Isogenica Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12102018 Prices from USD $250

Oct 31, 2018

12:34 EDT 31 Oct 2018 | BioPortfolio Reports Summary Isogenica Ltd Isogenica, formerly Pharmacophorix Ltd is a developer of synthetic antibody libraries and display technologies. The company owns peptide and antibody domain libraries. It also operates both phage display and a proprietary invitro display. Isogenica's colibra technology is applicable in the critical stages of drug discovery and biologics development and also improves efficiency of antibody discovery projects. The company also offers analytical screening, which include cell based screening, cell sorting and biophysical analyses. The company caters to pharmaceutical and biotechnology companies. Isogenica is headquartered in Little Chesterford, the UK. Isogenica Ltd Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Isogenica Frequently Asked Questions (FAQ)

  • When was Isogenica founded?

    Isogenica was founded in 2000.

  • Where is Isogenica's headquarters?

    Isogenica's headquarters is located at Essex.

  • What is Isogenica's latest funding round?

    Isogenica's latest funding round is Unattributed.

  • Who are the investors of Isogenica?

    Investors of Isogenica include Innovate UK.

  • Who are Isogenica's competitors?

    Competitors of Isogenica include Evotec SE, Oxford BioTherapeutics, Galil Medical, Provepep, AI2 and 12 more.

Compare Isogenica to Competitors

Actinobac Biomed

Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Its drug candidates are based upon Leukothera (LtxA), a natural protein that targets and eliminates white blood cells (WBCs) involved in the mechanism of many diseases. Products based upon Leukothera are being developed by Actinobac for the treatment of leukemia/lymphoma, dry eye, and psoriasis.


AI2 is a spin-out from the Faculty of Life Sciences. The company has peptide technology which it is developing for a range of antimicrobial coating and therapeutic applications.

Oxford BioTherapeutics Logo
Oxford BioTherapeutics

Oxford BioTherapeutics is an international, clinical-stage biotechnology company focused on developing antibody-based therapies to treat cancer. Combining immuno-oncology, antibody-drug conjugates, and fully human monoclonal antibody approaches against novel human tumor cell membrane-derived checkpoint targets identified using its unique target selection and validation platform, the Company has gathered compelling in vivo evidence of the potency of its broad pipeline.


Antivirals is engaged in the discovery of agents that inhibit replication of human pathogenic viruses.


Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.


DermaGen develops peptide therapeutics for topical use based on antimicrobial peptides (AMPs).

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.